Published ahead of print on December 18, 2008, doi:10.1164/rccm.200804-592OC © 2009 American Thoracic Society doi: 10.1164/rccm.200804-592OC
Alveolar Type II Epithelial Cells Present Antigen to CD4+ T Cells and Induce Foxp3+ Regulatory T Cells1 Immune Regulation Group, Helmholtz Centre for Infection Research, Braunschweig, Germany; 2 Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; and 3 Department of Medical Microbiology, University Hospital Essen, Essen, Germany Correspondence and requests for reprints should be addressed to Dunja Bruder, Ph.D., Immune Regulation Group, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany. E-mail: dunja.bruder{at}helmholtz-hzi.de Rationale: Although the contribution of alveolar type II epithelial cells (AECIIs) in respiratory immunity has become increasingly appreciated, their precise function in the induction and regulation of T-cell reactivity to self-antigen remains poorly understood. Objectives: To investigate the role of AECII in the initiation of T-cell reactivity to alveolar self-antigen, and to clarify their function in the peripheral induction of Foxp3+ regulatory CD4+ T cells. Methods: To dissect the complex cellular and molecular functions of AECIIs in lung inflammation and immune regulation, we use a transgenic mouse model for CD4+ T-cell–mediated pulmonary inflammation. Measurements and Main Results: Here we report that AECIIs present endogenously expressed antigen on major histocompatibility complex class II molecules to CD4+ T cells. Epithelial antigen display was sufficient to induce primary T-cell activation and pulmonary inflammation. Upon inflammation, AECIIs induce the differentiation of Foxp3+ regulatory T cells by a mechanism involving antiproliferative soluble factors, including transforming growth factor (TGF)-β. Whereas, in acute inflammation, TGF-β appears to be the dominant factor to induce regulatory T cells, other AECII-derived factors can substitute for and/or synergize with TGF-β in chronic pulmonary inflammations. Conclusions: AECIIs are capable of priming naive CD4+ T cells, demonstrating an active participation of these cells in respiratory immunity. Moreover, AECIIs display as yet unrecognized functions in balancing inflammatory and regulatory T-cell responses in the lung by connecting innate and adaptive immune mechanisms to establish peripheral T-cell tolerance to respiratory self-antigen.
Key Words: peripheral tolerance alveolar type II epithelial cells immune regulation autoimmunity transgenic mouse model
Related articles in AJRCCM:
This article has been cited by other articles:
|
|
|||||||||||||||||||||||||||||||||||||||||||